Intematix Corporation provided an update on its patent infringement litigation in South Korea with Mitsubishi Chemical Corporation.

Intematix reported that on February 5, 2013 the Seoul Central District Court decided not to issue any enforceable ruling at this time. Accordingly, there is no restriction on any sales or use of Intematix R or ER products in South Korea.  The litigation remains on-going.

“We will continue to vigorously defend ourselves in any litigation,” commented Intematix General Counsel, Tom MacMitchell.  “We remain confident that Intematix ultimately will be successful.”

As a reminder, this litigation only relates to Intematix R and ER products within South Korea.  Intematix offers a number of other next-generation, proprietary red nitride solutions, including its RR and XR series red nitride products.  Intematix RR series red nitride products have a unique formulation, which is protected by U.S. Patent No. 8,274,215.  Intematix XR series red nitride products, which are Intematix’s newest red nitride offerings, are based on an entirely different structure.